Apc loss has also been shown to cooperate with hepsin overexpression or Smad4 loss to promote invasive prostate cancer, further indicating that invasive progression in Apc-deficient prostate cancer requires an additional genetic alteration [196,197]. The gene discussed is APC; the disease is prostate carcinoma.